Xenon Pharmaceuticals Inc (XENE) — Strategic Asset Allocation Index
Xenon Pharmaceuticals Inc (XENE) has a Strategic Asset Allocation Index of 16.6% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $92.99 Million) total $92.99 Million, measured against net assets of $559.51 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Xenon Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Xenon Pharmaceuticals Inc Strategic Asset Allocation Index (2012–2024)
This chart shows how Xenon Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 16.6%, representing strategic assets of $92.99 Million against net assets of $559.51 Million USD. See Xenon Pharmaceuticals Inc (XENE) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Xenon Pharmaceuticals Inc (2012–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Xenon Pharmaceuticals Inc from 2012 to 2024, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Xenon Pharmaceuticals Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 16.9% | $127.50 Million | $- | $127.50 Million | $754.90 Million | ▼ -14.7 pp |
| 2023 | 31.6% | $292.79 Million | $- | $292.79 Million | $927.92 Million | ▲ +12.8 pp |
| 2022 | 18.7% | $135.18 Million | $6.50 Million | $128.68 Million | $721.50 Million | ▲ +17.9 pp |
| 2021 | 0.8% | $4.47 Million | $4.47 Million | $0.00 | $550.03 Million | ▼ -1.3 pp |
| 2020 | 2.1% | $3.55 Million | $3.55 Million | $- | $171.35 Million | ▲ +0.3 pp |
| 2019 | 1.8% | $1.66 Million | $1.66 Million | $- | $91.98 Million | ▲ +0.8 pp |
| 2018 | 1.0% | $991.00K | $991.00K | $- | $103.30 Million | ▼ -2.0 pp |
| 2017 | 3.0% | $1.07 Million | $1.07 Million | $- | $35.93 Million | ▲ +0.8 pp |
| 2016 | 2.2% | $1.40 Million | $1.40 Million | $- | $63.90 Million | ▼ -1.1 pp |
| 2015 | 3.3% | $1.99 Million | $1.99 Million | $- | $61.03 Million | ▼ -0.1 pp |
| 2014 | 3.4% | $2.48 Million | $2.48 Million | $- | $72.78 Million | ▼ -4.4 pp |
| 2013 | 7.8% | $1.88 Million | $1.88 Million | $- | $24.12 Million | ▼ -12.8 pp |
| 2012 | 20.6% | $2.60 Million | $2.60 Million | $- | $12.62 Million | — |